Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H1 2012 (Related Reports)

Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H1 2012


April 19, 2012
119 Pages - SKU: GMD3866357
License type:
Online Download      US $500.00
Site License      US $1,000.00
Global Site License      US $1,500.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018
4/14/2014 | published by: MarketsandMarkets
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018 The global cell analysis market  |  read more...
$4,650.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
4/14/2014 | published by: GBI Research
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business intelligence provider GBI Research has released its latest research report,  |  read more...
$3,500.00
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 provides data on the Metastatic Renal Cell Carcinoma clinical trial scenario. This  |  read more...
$2,500.00
Conference Documentation: Asthma & COPD
4/2/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Asthma & COPD SMi proudly present their 10th annual Asthma and COPD conference taking place in Central London on Wednesday 2nd and Thursday 3rd April, 2014.  This year’s event will focus  |  read more...
$788.78
Urinary Tract Infections - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Urinary Tract Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Urinary Tract Infections - Pipeline Review, H1 2014’, provides an overview of the Urinary Tract Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Dyskinesia - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Dyskinesia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H1 2014’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyskinesia, complete with comparative  |  read more...
$2,000.00
Oral Mucositis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Oral Mucositis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Oral Mucositis - Pipeline Review, H1 2014’, provides an overview of the Oral Mucositis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oral  |  read more...
$2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Actinic (Solar) Keratosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Actinic (Solar) Keratosis - Pipeline Review, H1 2014’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00